+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report by Service (Bioanalytical Testing, Stability Testing), End-use (Pharmaceutical Companies, Biopharmaceutical Companies), and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 120 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 4764564
The Pharmaceutical Analytical Testing Outsourcing Market was valued at USD 8.96 billion in 2024, and is projected to reach USD 14.56 billion by 2030, rising at a CAGR of 8.60%. Increasing biological candidate pipelines, rising demand for additional analytical details on drugs, and process development by regulatory agencies are driving market growth. Analytical testing aids in real-time product quality control as well as help optimize and monitor processes, thereby identifying different drugs. Over the years, the number of clinical trials has increased consistently.

For instance, in 2021, over 399,525 clinical studies were registered on ClinicalTrial.gov, whereas as of June 2022, it had increased to over 421,258 studies. A continuation of this trend is expected to have a positive impact on the market in the post-pandemic period. The majority of small and medium-sized pharma companies lack the infrastructure for analytical testing. As a result, outsourcing these operations is the best option as it saves time and money. The patent cliff, primarily for small molecules and biologics, is likely to have a positive impact on the market as it will increase the number of commercial drugs in the pharma market, thus promoting the analytical testing of commercially available generic drugs.

There has been a rise in several diseases post-COVID-19. For instance, according to a report published by Children’s National Hospital- pediatric research and clinical innovations center, a study was performed on 737 youths who were diagnosed with diabetes, and it found an increased incidence of pediatric Type 1 Diabetes (T1D) by 15.2% and Type 2 Diabetes (T2D) increased by 182% between March 11, 2018, and March 10, 2021. The rise in disease incidence is expected to improve, drug production, which is likely to drive the demand for analytical services for commercial drugs .

Pharmaceutical Analytical Testing Outsourcing Market Report Highlights

  • The bioanalytical testing segment dominated the market, accounting for a revenue share of 38.44% in 2024. Bioanalytical testing covers both clinical and non-clinical studies.
  • The pharmaceutical segment gained the largest market share in 2024. The growing demand among pharmaceutical companies to focus on their core competencies is one of the major reasons for the largest segment share.
  • North America is expected to hold the largest revenue share of 52.91% owing to the presence of a significant number of pharmaceutical companies in the region.
  • Asia-Pacific is anticipated to be the fastest-growing regional market from 2025 to 2030 due to the low-cost service offerings by third-party service providers in the region.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Service
1.2.2. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Parent Market Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Pharmaceutical Analytical Testing Outsourcing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Clinical Trials Volume Analysis, (2024)
3.3.1. Total Number Of Clinical Trials By Region
3.3.2. Total Number Of Clinical Trials, By Phase
3.3.3. Total Number Of Clinical Trials, By Study Design
3.3.4. Total Number Of Clinical Trials, By Key Therapeutic Area
3.4. Pricing Model Analysis
3.5. Technology Landscape
3.6. Market Analysis Tools
3.6.1. Porter’s Five Force Analysis
3.6.2. PESTEL by SWOT Analysis
3.6.3. COVID-19 Impact Analysis
Chapter 4. Pharmaceutical Analytical Testing Outsourcing Market: Service Estimates & Trend Analysis
4.1. Pharmaceutical Analytical Testing Outsourcing Market, By Service: Segment Dashboard
4.2. Pharmaceutical Analytical Testing Outsourcing Market, By Service: Movement Analysis
4.3. Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, By Service, 2018-2030 (USD Million)
4.4. Bioanalytical Testing
4.4.1. Bioanalytical Testing Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4.2. Clinical
4.4.2.1. Clinical Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4.3. Non-Clinical
4.4.3.1. Non-Clinical Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Method Development & Validation
4.5.1. Method Development & Validation Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.2. Extractable & Leachable
4.5.2.1. Extractable & Leachable Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.3. Impurity Method
4.5.3.1. Impurity Method Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.4. Technical Consulting
4.5.4.1. Technical Consulting Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.5. Others
4.5.5.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6. Stability Testing
4.6.1. Stability Testing Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6.2. Drug Substance
4.6.2.1. Drug Substance Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6.3. Stability Indicating Method Validation
4.6.3.1. Stability Indicating Method Validation Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6.4. Accelerated Stability Testing
4.6.4.1. Accelerated Stability Testing Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6.5. Photostability Testing
4.6.5.1. Photostability Testing Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6.6. Others
4.6.6.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
4.7. Others
4.7.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. Pharmaceutical Analytical Testing Outsourcing Market: End Use Estimates & Trend Analysis
5.1. Pharmaceutical Analytical Testing Outsourcing Market, By End Use: Segment Dashboard
5.2. Pharmaceutical Analytical Testing Outsourcing Market, By End Use: Movement Analysis
5.3. Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, By End Use, 2018-2030 (USD Million)
5.4. Pharmaceutical Companies
5.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Biopharmaceutical Companies
5.5.1. Biopharmaceutical Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Contract Research Organizations
5.6.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. Pharmaceutical Analytical Testing Outsourcing Market: Regional Estimates & Trend Analysis
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2024 & 2030
6.3. North America
6.3.1. North America Market Estimates and Forecasts, 2018-2030 (USD Million)
6.3.2. U.S
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Framework
6.3.2.4. U.S. Market Estimates and Forecasts, 2018-2030 (USD Million)
6.3.3. Canada
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Framework
6.3.3.4. Canada Market Estimates and Forecasts, 2018-2030 (USD Million)
6.3.4. Mexico
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Regulatory Framework
6.3.4.4. Mexico Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4. Europe
6.4.1. Europe Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.2. UK
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. UK Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.3. Germany
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Germany Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.4. France
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. France Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.5. Italy
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Framework
6.4.5.4. Italy Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.6. Spain
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Framework
6.4.6.4. Spain Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.7. Sweden
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Regulatory Framework
6.4.7.4. Sweden Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.8. Denmark
6.4.8.1. Key Country Dynamics
6.4.8.2. Competitive Scenario
6.4.8.3. Regulatory Framework
6.4.8.4. Denmark Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.9. Norway
6.4.9.1. Key Country Dynamics
6.4.9.2. Competitive Scenario
6.4.9.3. Regulatory Framework
6.4.9.4. Norway Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.2. Japan
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Japan Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.3. China
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. China Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.4. India
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. India Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.5. Thailand
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. Thailand Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.6. South Korea
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. South Korea Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.7. Australia
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Australia Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6. Latin America
6.6.1. Latin America Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6.2. Brazil
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Brazil Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6.3. Argentina
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Argentina Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7. MEA
6.7.1. MEA Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7.2. South Africa
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. South Africa Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7.3. Saudi Arabia
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7.4. UAE
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. UAE Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Framework
6.7.5.4. Kuwait Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Company Market Share/Assessment Analysis, 2024
7.3. Company Profiles
7.3.1. SGS Société Générale de Surveillance SA
7.3.1.1. Company Overview
7.3.1.2. Financial Performance
7.3.1.3. Service Benchmarking
7.3.1.4. Strategic Initiatives
7.3.2. Labcorp
7.3.2.1. Company Overview
7.3.2.2. Financial Performance
7.3.2.3. Service Benchmarking
7.3.2.4. Strategic Initiatives
7.3.3. Eurofins Scientific
7.3.3.1. Company Overview
7.3.3.2. Financial Performance
7.3.3.3. Service Benchmarking
7.3.3.4. Strategic Initiatives
7.3.4. Pace Analytical Services LLC
7.3.4.1. Company Overview
7.3.4.2. Financial Performance
7.3.4.3. Service Benchmarking
7.3.4.4. Strategic Initiatives
7.3.5. Intertek Group plc
7.3.5.1. Company Overview
7.3.5.2. Financial Performance
7.3.5.3. Service Benchmarking
7.3.5.4. Strategic Initiatives
7.3.6. PPD Inc (Thermo Fisher Scientific Inc.)
7.3.6.1. Company Overview
7.3.6.2. Financial Performance
7.3.6.3. Service Benchmarking
7.3.6.4. Strategic Initiatives
7.3.7. Wuxi AppTec
7.3.7.1. Company Overview
7.3.7.2. Financial Performance
7.3.7.3. Service Benchmarking
7.3.7.4. Strategic Initiatives
7.3.8. BA Sciences
7.3.8.1. Company Overview
7.3.8.2. Financial Performance
7.3.8.3. Service Benchmarking
7.3.8.4. Strategic Initiatives
7.3.9. Charles River Laboratories
7.3.9.1. Company Overview
7.3.9.2. Financial Performance
7.3.9.3. Service Benchmarking
7.3.9.4. Strategic Initiatives
7.3.10. West Pharmaceutical Services, Inc
7.3.10.1. Company Overview
7.3.10.2. Financial Performance
7.3.10.3. Service Benchmarking
7.3.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 4 Global Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 5 Global Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Region, 2018-2030 (USD Million)
Table 6 North America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 7 North America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 8 North America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 9 U.S. Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 10 U.S. Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 11 Canada Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 12 Canada Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 13 Mexico Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 14 Mexico Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 15 Europe Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 16 Europe Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 17 Europe Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 18 UK Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 19 UK Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 20 Germany Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 21 Germany Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 22 France Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 23 France Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 24 Italy Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 25 Italy Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 26 Spain Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 27 Spain Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 28 Denmark Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 29 Denmark Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 30 Sweden Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 31 Sweden Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 32 Norway Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 33 Norway Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 34 Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 35 Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 36 Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 37 Japan Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 38 Japan Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 39 China Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 40 China Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 41 India Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 42 India Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 43 Thailand Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 44 Thailand Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 45 South Korea Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 46 South Korea Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 47 Australia Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 48 Australia Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 49 Latin America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 50 Latin America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 51 Latin America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 52 Brazil Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 53 Brazil Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 54 Argentina Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 55 Argentina Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 56 Middle East & Africa Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 57 Middle East & Africa Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 58 Middle East & Africa Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 59 South Africa Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 60 South Africa Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 61 Saudi Arabia Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 62 Saudi Arabia Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 63 UAE Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 64 UAE Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 65 Kuwait Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 66 Kuwait Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Market formulation & validation
Figure 6 Commodity flow analysis
Figure 7 Value-chain-based sizing & forecasting
Figure 8 QFD model sizing & forecasting
Figure 9 Bottom-up approach
Figure 10 Market snapshot
Figure 11 Segment snapshot 1
Figure 12 Segment snapshot 2
Figure 13 Competitive landscape snapshot
Figure 14 Parent market outlook, 2024 (USD Billion)
Figure 15 Ancillary market outlook, 2024 (USD Billion)
Figure 16 Pharmaceutical Analytical Testing Outsourcing Market Dynamics
Figure 17 Porter’s five forces analysis
Figure 18 PESTEL analysis
Figure 19 Pharmaceutical Analytical Testing Outsourcing Market: Service outlook and key takeaways
Figure 20 Pharmaceutical Analytical Testing Outsourcing Market: Service movement analysis
Figure 21 Bioanalytical Testing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 22 Clinical Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 23 Non-Clinical Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 24 Method Development & Validation Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 25 Extractable & Leachable Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 26 Impurity Method Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 27 Technical Consulting Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 28 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 29 Stability Testing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 30 Drug Substance Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 31 Stability Indicating Method Validation Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 32 Accelerated Stability Testing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 33 Photostability Testing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 34 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 35 Others Service Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 36 Pharmaceutical Analytical Testing Outsourcing Market: End Use outlook and key takeaways
Figure 37 Pharmaceutical Analytical Testing Outsourcing Market: End Use movement analysis
Figure 38 Pharmaceutical Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 39 Biopharmaceutical Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 40 Contract Research Organizations Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 41 Regional Marketplace: Key Takeaways
Figure 42 North America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 43 Key Country Dynamics
Figure 44 U.S. Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 45 Key Country Dynamics
Figure 46 Canada Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 47 Key Country Dynamics
Figure 48 Mexico Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 49 Europe Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 50 Key Country Dynamics
Figure 51 UK Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 52 Key Country Dynamics
Figure 53 Germany Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 54 Key Country Dynamics
Figure 55 France Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 56 Key Country Dynamics
Figure 57 Italy Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 58 Key Country Dynamics
Figure 59 Spain Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 60 Key Country Dynamics
Figure 61 Denmark Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 62 Key Country Dynamics
Figure 63 Sweden Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 64 Key Country Dynamics
Figure 65 Norway Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 66 Key Country Dynamics
Figure 67 Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 68 Key Country Dynamics
Figure 69 Japan Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 70 Key Country Dynamics
Figure 71 China Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 72 Key Country Dynamics
Figure 73 India Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 74 Key Country Dynamics
Figure 75 Thailand Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 76 Key Country Dynamics
Figure 77 South Korea Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 78 Key Country Dynamics
Figure 79 Australia Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 80 Latin America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 81 Key Country Dynamics
Figure 82 Brazil Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 83 Key Country Dynamics
Figure 84 Argentina Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 85 MEA Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 86 Key Country Dynamics
Figure 87 South Africa Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 88 Key Country Dynamics
Figure 89 Saudi Arabia Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 90 Key Country Dynamics
Figure 91 UAE Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 92 Key Country Dynamics
Figure 93 Kuwait Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 94 Key company categorization
Figure 95 Service heat map analysis
Figure 96 Strategic framework

Companies Mentioned

The major companies featured in this Pharmaceutical Analytical Testing Outsourcing market report include:
  • SGS Société Générale de Surveillance SA
  • Labcorp
  • Eurofins Scientific
  • Pace Analytical Services LLC
  • Intertek Group plc
  • Thermo Fisher Scientific Inc.
  • Wuxi AppTec
  • BA Sciences
  • Charles River Laboratories
  • West Pharmaceutical Services, Inc

Table Information